Louisiana HB869 expands health insurance coverage to include injectable drugs for glucose level improvement or weight loss.
Louisiana HB869 mandates that health coverage plans in the state provide coverage for injectable drugs approved by the FDA for lowering glucose levels or for weight loss. This applies if the drug is prescribed for prediabetes, gestational diabetes, or obesity, and the individual is diagnosed with one of these conditions. The coverage may include annual deductibles, coinsurance, and copayments, and may require prior authorization. The law also allows plans to mandate participation in a lifestyle management plan, if available.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.